Novavax (NVAX) option implied volatility into FDA granted EUA for COVID-19 vaccine
June 8, 2022 5:20 AM
Novavax (NASDAQ: NVAX) 30-day option implied volatility is at 145; compared to its 52-week range of 64 to 167 into FDA granted EUA for COVID-19 vaccine.
